Double-blind, Placebo-controlled Study of BGC20-1531 in Migraine
- First Posted Date
- 2009-04-28
- Last Posted Date
- 2022-06-03
- Lead Sponsor
- Boston Scientific Corporation
- Registration Number
- NCT00888680
- Locations
- 🇩🇰
Danish Headache Center, Glostrup, Denmark
🇳🇴Head and Neck Research Group, Oslo, Norway
🇳🇴Norwegian National Headache Centre, Trondheim, Norway
Optimized Programming in Spinal Cord Stimulation (SCS) System
- Conditions
- Neuropathic PainPain
- Interventions
- Device: Precision Spinal Cord Stimulation (SCS)
- First Posted Date
- 2009-03-30
- Last Posted Date
- 2013-11-27
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT00871819
- Locations
- 🇺🇸
University of California, San Diego Medical Center, San Diego, California, United States
Initial Chronic Human Validation Study: Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) System
- Conditions
- Ventricular Tachyarrhythmias
- Interventions
- Device: Subcutaneous Implantable Defibrillator (S-ICD) System
- First Posted Date
- 2009-03-02
- Last Posted Date
- 2021-07-06
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 6
- Registration Number
- NCT00853645
- Locations
- 🇳🇿
Auckland City Hospital, Auckland, New Zealand
🇳🇿Christchurch Hospital, Christchurch, New Zealand
ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology
- Conditions
- Atrial Fibrillation
- Interventions
- Device: WATCHMAN
- First Posted Date
- 2009-02-26
- Last Posted Date
- 2015-01-27
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 150
- Registration Number
- NCT00851578
- Locations
- 🇨🇿
NA Homolce Hospital, Prague, Czech Republic
🇩🇪Sankt Katharinen Hospital / Cardiovasculares Centrum, Frankfurt, Germany
🇩🇪Herzzentrum Leipzig, Leipzig, Germany
Atrial Fibrillation: Canadian Atrial Fibrillation Evaluation (CAFE) Study -
- Conditions
- Atrial Fibrillation
- Interventions
- Device: Guidant Pulsar Max II or Insignia Plus DRDevice: Atrial pacing preference turned on or off
- First Posted Date
- 2009-02-20
- Last Posted Date
- 2021-05-12
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 270
- Registration Number
- NCT00848445
Study of Chemoembolisation Using Irinotecan Bead Prior to Surgery in Metastatic Colorectal Cancer
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- Device: Irinotecan Bead
- First Posted Date
- 2009-02-16
- Last Posted Date
- 2021-07-21
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT00844233
- Locations
- 🇦🇹
Medical University Vienna, AKH, Vienna, Austria
🇫🇷Centre Hépato-Biliaire, Hôpital Paul Brousse, Villejuif, France
🇬🇧Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke, United Kingdom
A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™)
- Conditions
- AtherosclerosisCoronary Artery Disease
- Interventions
- Device: PROMUS Element™
- First Posted Date
- 2009-01-16
- Last Posted Date
- 2012-08-30
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT00824434
- Locations
- 🇦🇺
St. Vincent's Hospital - Sydney, Darlinghurst, New South Wales, Australia
🇦🇺Royal North Shore Hospital, St Leonards, New South Wales, Australia
🇦🇺Monash Medical Centre, Clayton, Victoria, Australia
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
- Conditions
- Coronary Artery Disease
- Interventions
- Device: PROMUS Coronary Stent SystemDevice: PROMUS Element Coronary Stent SystemDrug: Thienopyridine
- First Posted Date
- 2009-01-15
- Last Posted Date
- 2019-03-27
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 1530
- Registration Number
- NCT00823212
- Locations
- 🇺🇸
Baptist Medical Center Princeton, Birmingham, Alabama, United States
🇺🇸Banner Good Samaritan Regional Medical Center, Phoenix, Arizona, United States
🇺🇸Arkansas Heart Hospital, Little Rock, Arkansas, United States
Evaluation of Left Ventricular AutoThreshold
- Conditions
- Heart Failure
- Interventions
- Device: No intervention is used. Collection of signals only.
- First Posted Date
- 2008-12-22
- Last Posted Date
- 2022-06-28
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 80
- Registration Number
- NCT00812201
- Locations
- 🇺🇸
Virginia Commonwealth University Health System, Richmond, Virginia, United States
🇺🇸Monongalia General Hospital, Morgantown, West Virginia, United States
Safety of Bronchial Thermoplasty Performed With the Alair® System During Two Treatment Sessions to Treat Severe Asthma
- Conditions
- Asthma
- Interventions
- Device: The Alair System
- First Posted Date
- 2008-12-05
- Last Posted Date
- 2021-02-01
- Lead Sponsor
- Boston Scientific Corporation
- Registration Number
- NCT00803088